KK-R002

N/A

Report date: 2025/01/13 15:26:41

Base Information

Drug NameKK-R002
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunity Acquired Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnhui Kangzheng Kangren Pharmaceutical Co LtdAnhui Kangzheng Kangyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Kangzheng Kangyuan Pharmaceutical Co LtdAnhui Kangzheng Kangren Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCommunity Acquired Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A